Paul Tudor Jones Codexis, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Codexis, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 106,365 shares of CDXS stock, worth $449,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,365
Previous 58,093
83.09%
Holding current value
$449,923
Previous $178,000
184.83%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
60.6MCall Options Held
68.5KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.84MShares$37.4 Million8.29% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$34.3 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$18.9 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$12.7 Million1.53% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $277M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...